Figure 6
Incidence of MACE at 24 months follow-up according to diagnostic assessments (A) and personalized therapy (B). Angio, coronary angiography; ACH, acetylcholine provocation test; FFR, fractional flow reserve assessment; CCB, calcium-channel blockers; BB, beta-blockers.

Incidence of MACE at 24 months follow-up according to diagnostic assessments (A) and personalized therapy (B). Angio, coronary angiography; ACH, acetylcholine provocation test; FFR, fractional flow reserve assessment; CCB, calcium-channel blockers; BB, beta-blockers.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close